News › Industry News, News, Spotlights

Stemson Therapeutics Secures $7.5 Million Financing for Development of Hair Regeneration Therapy

September 16, 2020

Stemson Therapeutics has announced a $7.5-million seed financing led by Allergan Aesthetics, an AbbVie Company, and impact investor Fortunis Capital to advance development of Stemson’s therapeutic solution to cure hair loss. Stemson aims to restore human hair growth with a novel approach using the patient’s own cells to generate new hair follicles. Allergan Aesthetics is a world-leading medical aesthetics company. Fortunis Capital, a London-based venture capital firm, is committed to continuing support of Stemson’s regenerative cell therapy to treat hair loss. Fortunis Capital’s new Impact Fund intends to invest in companies, such as Stemson, that offer significant social or environmental benefit.
Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education
    • Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation
    • Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides
    • Weave Supports AmSpa Members as Platinum Vendor Affiliate
    • Allergan Aesthetics Says the Future of Aesthetics Is Layered
Advertisement